Literature DB >> 27221213

Polymorphisms of BDNF and CACNA1C are not associated with cognitive functioning in bipolar disorder or healthy controls.

Sindre Rolstad1, Carl Sellgren Majkowitz2, Erik Joas1, Carl Johan Ekman3, Erik Pålsson1, Mikael Landén1,2,3.   

Abstract

INTRODUCTION: The cause of cognitive dysfunction in bipolar disorder (BD) is not well understood. BDNF and CACNA1C are two susceptibility genes for the disorder that have also been reported to be associated with cognitive deficits in the disorder, but the studies have been small and with conflicting results. We therefore attempted to replicate an association between cognitive dysfunction with the most commonly studied single nucleotide polymorphisms rs6265 and rs1006737.
METHODS: Regression models with five aggregated cognitive domains derived from a comprehensive test battery and IQ score were run using directly genotyped risk variants of SNPs rs6265 and rs1006737 as predictors with covariates as appropriate. Models were performed in a clinical sample of Swedish patients with BD (N = 114) and sex- and age-matched population controls (N = 104).
RESULTS: No significant associations (regardless of correction for multiple testing) between the BDNF and CACNA1C risk variants and cognitive functioning were found in either patients or controls.
CONCLUSIONS: Our results do not support that the common genetic risk variants in rs6265 and rs1006737 are associated with cognitive dysfunction.

Entities:  

Keywords:  Single nucleotide polymorphisms; bipolar disorder; cognition

Mesh:

Substances:

Year:  2016        PMID: 27221213     DOI: 10.1080/13546805.2016.1185405

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  4 in total

1.  CACNA1C polymorphism and brain cortical structure in bipolar disorder

Authors:  Erik Smedler; Christoph Abé; Erik Pålsson; Martin Ingvar; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2019-12-12       Impact factor: 6.186

2.  A molecular approach to treating cognition in schizophrenia by calcium channel blockade: An open-label pilot study of the calcium-channel antagonist isradipine.

Authors:  Katherine E Burdick; Mercedes Perez-Rodriguez; Rebecca Birnbaum; Megan Shanahan; Emmett Larsen; Cierra Harper; Jessica Poskus; Pamela Sklar
Journal:  Schizophr Res Cogn       Date:  2020-05-18

3.  CACNA1C polymorphisms Impact Cognitive Recovery in Patients with Bipolar Disorder in a Six-week Open-label Trial.

Authors:  Kangguang Lin; Guiyun Xu; Lingling Shi; Weicong Lu; Lijie Guan; Huiyi Ouyang; Kun Chen; Yamei Dang; Libing Zhou; Kwok-Fai So
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

4.  The BDNF Val66Met Polymorphism Has No Effect on Encoding-Related Hippocampal Response But Influences Recall in Remitted Patients With Bipolar Disorder.

Authors:  Lone Diana Hørlyck; Julian Macoveanu; Maj Vinberg; Lars Vedel Kessing; Hartwig Roman Siebner; Kamilla Woznica Miskowiak
Journal:  Front Psychiatry       Date:  2019-12-06       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.